FDA issues guidance on excipients for anti-counterfeiting; API-maker Rhodes accused of hazardous waste violations;

> The FDA has issued final guidance for the use of chemical identifiers for anti-counterfeiting. Guidance

> API-maker Rhodes Technologies, accused by the U.S. Environmental Protection Agency of violating hazardous waste laws, could be fined more than $250,000. Story

> NovaSterilis has been granted U.S. Patent 8,012,414 B2, "Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant." Release

> Chiesi Farmaceutici Spain will upgrade its CRM system to the Mobile Intelligence SaaS CRM Solution from Cegedim Relationship Management. Release

> Maria Crowe, senior VP for global drug product manufacturing, is being promoted to succeed retiring, 36-year vet Frank Deane as president of manufacturing operations at Eli Lilly ($LLY). Release

> The Indian Ministry of Health has approved a proposal to put 2D barcodes and scratch-off labels on medicines as a means of fighting counterfeiting. Story

> DASGIP, a supplier of parallel benchtop bioreactor systems, has unveiled the DASware bioprocessing solution for management of bioprocessing data. Release

> Cardinal Health has gained exclusive rights to distribute MicroPhage's KeyPath MRSA/MSSA blood testing kits in the U.S. and Canada in exchange for operational funding to develop products based on the same testing technology. Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.